Manufacturers

Trial of a Lifetime: Worker’s Battle with Silicosis Puts Engineered Stone Manufacturers in the Legal Spotlight

by

Los Angeles – Gustavo Reyes Gonzalez, a stonecutter, now breathes with the aid of transplanted lungs, his own destroyed by years of inhaling fine particles from cutting engineered stone, a popular material for countertops. His harrowing experience opens the door to a legal battle in Los Angeles County, raising urgent questions about industry responsibilities and worker safety. Reyes Gonzalez, a worker in Orange County’s fabrication shops, would spend his days slicing through slabs of the artificial stone, which, while aesthetically pleasing, contains dangerous levels of crystalline silica. Despite its durability and stain resistance, the engineered … Read more

Weight-Loss Drug Manufacturers Strategize Defenses Learning From U.S. Mass Tort Litigation History

by

Washington, D.C. – As the pharmaceutical landscape evolves, manufacturers of popular GLP-1 weight-loss drugs find themselves at a crossroads, facing potential legal challenges reminiscent of previous cases in the U.S. pharmaceutical history. These companies, harnessing the attributes of the glucagon-like peptide-1 receptor agonists, must draw on lessons from past litigation to strategically fortify themselves against similar future challenges. Manufacturers are currently benefiting from a surge in the popularity of these drugs, lauded for their effectiveness in weight management. The increasing prevalence of obesity across the country has driven demand, positioning GLP-1 receptor agonists as key … Read more

Insights from U.S. Litigation History: Navigating Legal Challenges for GLP-1 Weight-Loss Drug Manufacturers

by

New York – As the battle against obesity intensifies in the United States, the spotlight has turned towards a promising class of weight-loss drugs known as glucagon-like peptide-1 receptor (GLP-1) agonists. These medications, initially developed to treat diabetes, have shown significant efficacy in weight management, offering a new hope for millions struggling with obesity. However, the burgeoning demand and dramatic effects of these drugs have also raised concerns about potential legal challenges that may echo America’s complex history with mass tort litigation involving pharmaceutical companies. The risk of facing massive lawsuits is not misplaced. In … Read more

Breaking Ground: Firefighters Challenge Health Risks with Novel Lawsuit Against AFFF Manufacturers

by

Washington, D.C. – Across the Unitedranked States, firefighters who have long relied on aqueous film-forming foam (AFFF) for extinguishing severe fires, particularly those involving flammable liquids, are now confronting a dire health crisis. Studies have linked the chemicals in AFFF to a variety of serious health issues, sparking a wave of litigation aimed at manufacturers. Aqueous film-forming foam, commonly used since the 1960s in military and civilian firefighting operations, contains per- and polyfluoroalkyl substances (PFAS), also referred to as “forever chemicals.” PFAS are highly valued for their effectiveness in dousing fuel and oil fires but … Read more